⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30295272 | 1.00 | — | — | |
| SCHEMBL27439362 | 0.78 | CYP11B2 (0.44) | — | |
| SCHEMBL29562545 | 0.77 | — | — | |
| SCHEMBL5700328 | 0.77 | — | — | |
| SCHEMBL20448774 | 0.77 | — | — | |
| SCHEMBL29500425 | 0.76 | NPY5R (0.45) | — | |
| SCHEMBL9792784 | 0.76 | NPY5R (0.45) | — | |
| SCHEMBL29598148 | 0.74 | CLK4 (0.44) | — | |
| SCHEMBL995799 | 0.74 | CLK4 (0.44) | — | |
| SCHEMBL931687 | 0.74 | CYP1A1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 431 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479824-B2 | Method for preparing ivosidenib and an intermediate thereof | SERVIER PHARMACEUTICALS LLC (US) | 2025-11-25 | — | — | US | claimed |
| CN-118580235-A | Preparation method of lactam compound | 正大天晴药业集团股份有限公司 | 2024-09-03 | — | — | CN | claimed |
| EP-4010331-B1 | A METHOD FOR PREPARING IVOSIDENIB AND AN INTERMEDIATE THEREOF | SERVIER LAB (FR) | 2023-10-04 | — | — | EP | claimed |
| CN-115724793-A | Preparation method of 2-bromoisonicotinic acid nitrile | 山西永津集团有限公司 | 2023-03-03 | — | — | CN | claimed |
| US-20230025411-A1 | A METHOD FOR PREPARING IVOSIDENIB AND AN INTERMEDIATE THEREOF | SERVIER PHARMACEUTICALS LLC | 2023-01-26 | — | — | US | claimed |
| EP-4010331-A1 | A METHOD FOR PREPARING IVOSIDENIB AND AN INTERMEDIATE THEREOF | Les Laboratoires Servier (FR) | 2022-06-15 | — | — | EP | claimed |
| WO-2021079380-A1 | IMPROVED PROCESS FOR THE PREPARATION OF (2S)-N-{(1S)-1-(2-CHLOROPHENYL)-2-[(3,3-DIFLUOROCYCLOBUTYL)-AMINO]-2-OXOETHYL}-1-(4-CYANOPYRIDIN-2-YL)-N-(5-FLUOROPYRIDIN-3-YL)-5-OXOPYRROLIDINE-2-CARBOXAMIDE | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2021-04-29 | — | — | WO | claimed |
| WO-2021026436-A1 | A METHOD FOR PREPARING IVOSIDENIB AND AN INTERMEDIATE THEREOF | AGIOS PHARMACEUTICALS, INC. (US) | 2021-02-11 | — | — | WO | claimed |
| WO-2020127887-A1 | PROCESS FOR THE PREPARATION OF AN INTERMEDIATE PRODUCT OF IVOSIDENIB | SANDOZ AG (CH) | 2020-06-25 | — | — | WO | claimed |
| EP-4747258-A2 | COMPOUNDS, COMPOSITIONS, AND METHODS | Tenvie Therapeutics, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-3985001-B1 | PHARMACEUTICAL COMPOSITION FOR USE IN TREATING A CANCER | SERVIER LAB (FR) | 2026-04-29 | — | — | EP | disclosed |
| US-12606564-B2 | Adenosine receptor antagonist compounds | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2026-04-21 | — | — | US | disclosed |
| US-12552772-B2 | 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD | SPRINGWORKS THERAPEUTICS, INC. (US) | 2026-02-17 | — | — | US | disclosed |
| WO-2025262433-A1 | N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS | MISSION THERAPEUTICS LIMITED (GB) | 2025-12-26 | — | — | WO | disclosed |
| US-20100093703-A1 | SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-04-15 | — | — | US | disclosed |
| US-20100093703-A1 | SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-04-15 | — | — | US | disclosed |
| WO-2009134392-A1 | CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 | VITAE PHARMACEUTICALS, INC. (US) | 2009-11-05 | — | — | WO | disclosed |
| WO-2009017664-A1 | CYCLIC INHIBITORS OF 11β-HYDROXYSTERIOD DEHYDROGENASE 1 | VITAE PHARMACEUTICALS, INC. (US) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008099000-A2 | SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-08-21 | — | — | WO | disclosed |
| US-6200978-B1 | FOR PREVENTING OR TREATING INFLAMMATORY DISEASES SUCH AS ARTHRITIS, PSORIASIS, ASTHMA, OR INFLAMMATORY BOWEL DISEASE, DISORDERS OF RESPIRATORY FUNCTION, GASTROINTESTINAL DISORDERS SUCH AS FUNCTIONAL BOWEL DISEASE, AS ANALGESICS | PFIZER INC. | 2001-03-13 | — | — | US | disclosed |